Evaluation of cell survival, DNA double strand breaks, and DNA synthesis during concurrent camptothecin and X-radiation treatments

International Journal of Cancer

Volumn 96, Issue 5, 2001, Pages 277-285

  Ng, Cheng E ^a   Mazaheri, K ^a   Payant, C ^a   Raaphorst, G Peter ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Camptothecin; Cell survival; DNA synthesis; Double strand break; X radiation

Indexed keywords

CAMPTOTHECIN; DOUBLE STRANDED DNA;

ARTICLE; CANCER CELL CULTURE; CELL KILLING; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; CORRELATION FUNCTION; DNA STRAND BREAKAGE; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; X IRRADIATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL SURVIVAL; DNA; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENZYME INHIBITORS; HUMANS; THYMIDINE; TUMOR CELLS, CULTURED; X-RAYS;

EID: 0035922859     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1031     Document Type: Article

References (47)

1. Camptothecin radiation sensitivity: Mechanisms, schedules and timing
2. Concentration and timing dependence of lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiation
3. Radiation lethality enhancement with 9-aminocamptothecin: Comparison to other topoisomerase I inhibitors
4. Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines
5. The inhibition of cellular recovery in human tumor cells by inhibitors of topoisomerase
6. DNA damaging and cell cycle effects of the topoisomerase I poison camptothecin in irradiated human cells
7. Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan
8. Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan
9. Interaction of topoisomerase I inhibitors with radiation in cis-diamminedichloroplatinum (II)-sensitive and resistant cells in vitro and in the FSA IIc fibrosarcoma in vivo
10. Interaction of ionizing radiation with topotecan in two human tumor cell lines
11. Effects of SN-38 (an active metabolite of CPT-11) on responses of human and rodent cells to irradiation
12. SN-38, a metabolite of the CPT derivative CPT-11, potentiates the cytotoxic effect of radiation in human colon adenocarcinoma cells grown as spheroids
13. Mammalian DNA topoisomerase I mediates the enhancement of radiation cytotoxicity by camptothecin derivatives
14. Potentiation of murine MCa-4 carcinoma response by 9-amino-20(S)-CPT
15. Radiation enhancement by 9-aminocamptothecin: The effect of fractionation and timing of administration
16. Enhancement of tumor radioresponse by irinotecan in human lung tumor xenografts
17. Clinical status and optimal use of topotecan
18. The S-phase cytotoxicity of camptothecin
19. Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation
20. Effects of camptothecin on the breakage and repair of DNA during the cell cycle
21. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin
22. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells
23. Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA
24. Camptothecin resistance related to drug-induced down-regulation of topoisomerase I and to steps occurring after the formation of protein-linked DNA breaks
25. Interaction of ionizing radiation with the topoisomerase I poison camptothecin in growing V-79 and HeLa cells
26. Cross sensitivity to x-radiation and type I and II DNA topoisomerase inhibitors in a range of human and rodent cell lines
27. Comparison of thermoradiosensitization in two human melanoma cell lines and one fibroblast cell line by concurrent mild hyperthermia under low-dose-rate irradiation
28. Asymmetric field inversion gel electrophoresis: A new method for detecting DNA double-strand breaks in mammalian cells
29. Detection of DNA double strand breaks in synchronous cultures of CHO cells by means of asymmetric field inversion gel electrophoresis
30. Correlation between γ-ray induced DNA double-strand breakage and cell killing after biologically relevant doses: Analysis by pulsed-field gel electrophoresis
31. Multicell spheroid response to drugs predicted with the Comet assay
32. The human cell multiprotein DNA replication complex (MRC): The effect of camptothecin on its ability to support in vitro DNA synthesis
33. Comparison of effects of fostriecin, novobiocin, and camptothecin, inhibitors of DNA topoisomerases, on DNA replication and repair in human cells
34. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer
35. Chemoradiation of locally advanced esophageal cancer: Long-term follow up of a prospective randomized trial
36. Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery
37. Posttreatment exposure to camptothecin enhances the lethal effects of x-rays on radio-resistant human malignant melanoma cells
38. Processing of topoisomerase I cleavable complexes into DNA damage by transcription
39. Effects of ionizing radiation on DNA replication in cultured cells
40. X-ray inhibition of DNA synthesis in Chinese hamster ovary, human HeLa and mouse L cells
41. Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes
42. Targeting double strand breaks to replicating DNA identifies a subpathway of DSB repair that is defective in ataxia-telangiectasia cells
43. The chemoresistance of human malignant melanoma: An update
44. p53-dependent apoptosis in melanoma cells after treatment with camptothecin
45. Possible role of the multi-drug resistance associated protein (MRP) in chemoresistance of human melanoma cells